Page last updated: 2024-08-17

levodopa and Bradykinesia

levodopa has been researched along with Bradykinesia in 116 studies

Research

Studies (116)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's9 (7.76)18.2507
2000's51 (43.97)29.6817
2010's37 (31.90)24.3611
2020's19 (16.38)2.80

Authors

AuthorsStudies
Chen, Y; Cui, C; Cui, G; Xiao, Q; Xu, C; Zhang, W; Zu, J1
Glover, A; Kemp, AS; Larson-Prior, LJ; Lotia, M; Pillai, L; Spencer, H; Syeda, HB; Virmani, T1
Errico, V; Giannini, F; Lazzaro, GD; Pisani, A; Ricci, M; Saggio, G1
El-Masri, S; Evans, A; Malpas, CB; Walterfang, M1
Chen, Y; Du, T; Ma, R; Yuan, T; Zhang, J; Zhang, X; Zhu, G1
Bloem, BR; Boel, JA; de Bie, RMA; de Haan, RJ; Deuschl, G; Dijk, JM; Dijkgraaf, MGW; Frequin, HL; Lang, A; Munts, AG; Post, B; Schouten, J; Suwijn, SR; Tissingh, G; van Hilten, JJ; van Laar, T; Verschuur, CVM1
Cai, ZJ; Chang, PP; Li, YZ; Wei, LK; Yang, L; Zhang, GY; Zhang, XL; Zhang, YP; Zhu, DN1
Berardelli, A; Bologna, M; Fasano, A; Hallett, M; Paparella, G1
Bloem, BR; Dirkx, MF; Helmich, RC; Pasman, JW; Roth, D; Zach, H1
Bologna, M; De Angelis, A; Edwards, MJ; Faiman, I; Marsili, L; Morgante, F; Pereira, EA; Pradhan, P; Ricciardi, L1
Claus, I; Dziewas, R; Labeit, B; Muhle, P; Suntrup-Krueger, S; Suttrup, J; Warnecke, T1
Farzanehfar, P; Horne, M; Woodrow, H1
Batra, D; Bhattacharya, A; Holla, VV; Kamble, N; Pal, PK; Prasad, S; Sahoo, LK; Yadav, R1
Nascimento, D1
Abrami, A; Agurto, C; Caggiano, V; Heisig, S; Ho, BK1
Awad, N; Roy, D; Song, J; Zamudio, P1
Horne, M; Khodakarami, H; Shokouhi, N1
Barkan, S; Guan, I; Hellmers, N; Henchcliffe, C; Hou, Y; Malhotra, A; Sarva, H; Trabilsy, M; Wang, F1
Kang, SH; Kim, HJ; Koh, SB; Kwon, KY; Lee, HM; Pyo, SJ1
Coriolano, MDG; Lins, OG; Mota, IA1
Barbiani, D; Benedetti, F; Carlino, E; Dematteis, F; Frisaldi, E; Lanotte, M; Lopiano, L; Zibetti, M1
Baston, C; Ursino, M1
Alunni Fegatelli, D; Berardelli, A; Bologna, M; Giordo, L; Guerra, A; Paparella, G; Rothwell, JC; Vestri, AR1
Bordia, T; Perez, XA1
Cho, H; Lee, MJ; Lee, MS; Lee, SH; Lyoo, CH1
Reich, SG; Savitt, JM1
Konishi, O; Manabe, Y; Odawara, T1
Farzanehfar, P; Horne, M; Khodakarami, H1
Abosch, A; Francis, D; Ince, NF; Jimenez-Shahed, J; Ozturk, M; Wu, J1
Mastaglia, FL; Rodrigues, JP; Teo, WP; Thickbroom, GW1
Borroni, B; Cotelli, MS; Filosto, M; Marchina, E; Padovani, A; Premi, E1
Arfon, S; Drago, J; Evans, A; Griffiths, RI; Horne, MK; Johnson, W; Kempster, P; Kotschet, K; Raghav, S; Xu, ZM1
Bleuse, S; Defebvre, L; Delval, A; Devos, D; Moreau, C; Ryckewaert, G; Tard, C1
Hu, X; Huang, B; Li, H; Ma, Y; Rizak, JD; Yan, T; Yang, S1
Evans, AH; Griffiths, RI; Horne, M; Kettlewell, J; Kotschet, K; McGregor, S1
Gu, X; Han, L; Qiu, W; Tan, D; Ye, J; Zhang, H; Zhang, Y1
Hattori, N; Ishiguro, Y; Kawajiri, S; Noda, K; Okuma, Y; Tomizawa, Y; Tosaka, Y1
Bezard, E; Camus, SM; Ko, WKD; Li, Q; McGuire, S; Pioli, EY; Yang, J1
Amalric, M; Beurrier, C; Camon, J; Guiraudie-Capraz, G; Kerkerian-Le Goff, L; Liberge, M; Maurice, N; Ztaou, S1
Ahlskog, JE; Bower, J; Hassan, A; Josephs, KA; Klassen, B; Maraganore, D; Matsumoto, J; Owens, E; Savica, R1
Koehler, PJ; Marinus, J; Overmars, SS; Schilder, JC; van Hilten, JJ1
Grabli, D1
Jeon, BS; Kim, DG; Kim, HJ; Kim, JY; Lee, JY; Lim, YH; Paek, SH1
Aziz, T; Brown, P; Brücke, C; Kühn, AA; Kupsch, A; Ray, N; Schneider, GH; Tsui, A1
Li, J; McKeown, MJ; Wang, Z1
Fernandez, HH; Foote, KD; Garvan, CW; Haq, IU; Hass, CJ; Jacobson, CE; Malaty, IA; Mann, JM; Morishita, T; Okun, MS; Rodriguez, RL; Siddiqui, MS1
Cassin, J; Harris, O; Kelsey, JE1
Blume, SR; Cass, DK; Tseng, KY1
Brocco, M; Mela, F; Millan, MJ; Morari, M1
Cohen, H; Pourcher, E; Rémillard, S1
Azulay, JP; Cantiniaux, S; Horrelou-Pitek, C; Mancini, J; Robert, D; Vaugoyeau, M; Witjas, T1
Amanzio, M; Filippi, P; Geminiani, G; Giordano, A; Monteverdi, S; Soliveri, P1
Aeby, A; Blau, N; Burlina, A; de Klerk, JB; de Lonlay, P; de Rijk-van Andel, JF; Donati, MA; Geurtz, B; Grattan-Smith, PJ; Haeussler, M; Hoffmann, GF; Jung, H; Kamsteeg, EJ; Kok, F; Leuzzi, V; Megarbane, A; Monaghan, H; Renier, WO; Rondot, P; Ryan, MM; Seeger, J; Smeitink, JA; Steenbergen-Spanjers, GC; van der Knaap, MS; Verbeek, MM; Wassmer, E; Weschke, B; Wevers, RA; Wijburg, FA; Wilcken, B; Willemsen, MA; Zafeiriou, DI1
Rabey, JM; Stocchi, F1
Chen, R; Duker, AP; Dunn, E; Espay, AJ; Giuffrida, JP; Heldman, DA; Kim, SJ; Mazzella, F; Payne, M; Revilla, FJ; Sahay, A; Vaughan, JE1
Ondo, WG1
Christine, CW; Marks, WJ; Ostrem, JL1
Brown, P; Day, BL; Lees, AJ; Ling, H; Massey, LA1
Brown, P; Kuhn, AA; Little, S; Pogosyan, A1
Åström, M; Blomstedt, P; Forsgren, L; Fytagoridis, A; Hariz, MI; Linder, J1
Baraduc, P; Broussolle, E; Desmurget, M; Gan, J; Thobois, S1
Bjarnason, I; Charlett, A; Dobbs, RJ; Dobbs, SM; Iguodala, O; Lawson, AJ; Smee, C; Taylor, D; Weller, C1
Liou, HH; Liu, HM; Su, PC; Tseng, HM; Yen, RF3
Balash, Y; Bartels, AL; Giladi, N; Gurevich, T; Hausdorff, JM; Schaafsma, JD2
Bakay, RA; Barnhart, H; Chockkan, V; DeLong, MR; Evatt, M; Freeman, A; Green, J; Haber, M; McDonald, W; Mewes, K; Triche, S; Vitek, JL; Wahlay, N; Zhang, JY1
Calandrella, D; Martignoni, E; Riboldazzi, G; Riva, N1
Bembi, B; Capus, L; Carrozzi, M; Ciana, G; Gioulis, M; Martini, C; Pittis, MG; Sidransky, E; Zambito Marsala, S; Zorzon, M1
Bordet, R; Destee, A; Devos, D; Guieu, JD; Kroumova, M; Libersa, C; Vodougnon, H1
Lualdi, MM; Pasetti, C; Pinelli, P1
Blond, S; Bourriez, JL; Cassim, F; Defebvre, L; Derambure, P; Destée, A; Devos, D; Guieu, JD; Labyt, E; Reyns, N; Touzet, G1
Brocco, M; Brotchie, J; Crossman, A; Di Cara, B; Gobert, A; Hill, M; Jackson, M; Jenner, P; Joyce, JN; McGuire, S; Millan, MJ; Peglion, JL; Smith, L1
Antenor, J; Black, KJ; Burkey, A; Esper, GJ; Kotagal, V; Moerlein, SM; Ojemann, JG; Perlmutter, JS; Racette, BA; Videen, TO1
Gentilucci, M; Negrotti, A; Secchi, C1
Widnell, K1
Anderson, VC; Burchiel, KJ; Favre, J; Hammerstad, JP; Hogarth, P1
Deuschl, G; Govindan, RB; Morsnowski, A; Pohle, S; Raethjen, J; Wenzelburger, R1
Agostino, R; Bagnato, S; Berardelli, A; Dinapoli, L; Modugno, N1
Bakay, RA; Corcos, DM; Metman, LV; Prodoehl, J; Sturman, MM; Vaillancourt, DE1
Gielen, SC; Horstink, MW; Keijsers, NL1
Baba, Y; Putzke, JD; Uitti, RJ; Whaley, NR; Wszolek, ZK1
Bhat, V; Weiner, WJ1
Hattori, N; Inzelberg, R; Mizuno, Y1
Apetauerova, D; Corapi, K; Norregaard, T; O'Herron, S; Scollins, L; Tarsy, D1
Duval, C; Edwards, R; Ghassemi, M; Jog, M; Lemieux, S1
Constantoyannis, C; Honey, CR; Kumar, A; Mandat, T; Mercado, R; Schulzer, M; Stoessl, AJ1
Asmus, F; Bötzel, K; Deutschländer, A; Gasser, T; Klopstock, T; Marelli, E1
Kulkantrakorn, K; Pongchaiyakul, C; Pulkes, T; Tiamkao, S1
Huxham, F; Iansek, R; McGinley, J1
Chen, SY; Chien, SL; Hsin, YL; Lee, CW; Liang, CC; Lin, SH; Lin, SZ; Soong, YS1
Abu-Gharbieh, R; Au, WL; McCaig, RG; McKeown, MJ; Palmer, SJ; Saab, R1
Artuch, R; Camino, R; Lao-Villadóniga, JI; López-Laso, E; Mateos, ME; Ochoa, JJ; Ormazabal, A; Pérez-Navero, JL1
Bertoni, J; Kricorian, G; Leehey, M; Lew, MF; Pahwa, R1
Chung, SJ; Kim, SR; Lee, MC; Sung, YH1
Braun, M; Groiss, S; Gross, J; Krause, H; Maarouf, M; Ostrowski, S; Ploner, M; Pollok, B; Schnitzler, A; Sturm, V; Südmeyer, M; Timmermann, L; Voges, J; Wojtecki, L1
Goto, S; Hamasaki, T; Kuratsu, JI; Yamada, K1
Anderson, KE; Fishman, PS; Gruber-Baldini, AL; Reich, SG; Shulman, LM; Vaughan, CG; Weiner, WJ1
Braat, EA; Lighart, GJ; Middelkoop, HA; Roos, RA; van der Velde, EA; van Dijk, JG; van Hilten, JJ1
Laitinen, LV1
Charlton, CG; Crowell, B1
Bioulac, B; Boraud, T; Gross, C; Guehl, D; Julien, J; Rougier, A1
Bosch, DA; de Bie, RM; Schuurman, PR; Speelman, JD1
Ringendahl, H; Sierla, T1
Iansek, R; Matyas, T; Morris, M; Summers, J1
Ichikawa, S; Kitamura, S; Kuwana, Y; Nakamura, J; Shiozaki, S; Yamada, K1
Bräutigam, C; Hoffman, GF; Hyland, K; Knust, A; Sharma, RK; Wevers, RA1
Becker, G; Berg, D; Reiners, K1
Burns, JB; Connolly, CI; Jog, MS1
Ahlskog, JE; Muenter, MD1
Brotchie, JM; Crossman, AR; Fox, SH; Henry, B1
Côte, LJ; Fahn, S; Levy, G; Louis, ED; Marder, K; Mejia, H1
Abe, K; Miyatake, T; Ren, J; Sano, T; Shinohara, T; Taguchi, K; Utsunomiya, I; Wasai, T1
Fukaya, C; Kasai, M; Katayama, Y; Mizutani, T; Ogawa, K; Oshima, H; Yamamoto, T1
Bastian, AJ; Hyngstrom, AS; Kelly, VE; Rundle, MM1

Reviews

12 review(s) available for levodopa and Bradykinesia

ArticleYear
Evolving concepts on bradykinesia.
    Brain : a journal of neurology, 2020, 03-01, Volume: 143, Issue:3

    Topics: Animals; Humans; Hypokinesia; Levodopa; Neural Pathways; Parkinsonian Disorders

2020
Clinical features associated with drooling in Parkinson's disease.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021, Volume: 42, Issue:3

    Topics: Aged; Humans; Hypokinesia; Levodopa; Male; Parkinson Disease; REM Sleep Behavior Disorder; Sialorrhea

2021
Cholinergic control of striatal neurons to modulate L-dopa-induced dyskinesias.
    The European journal of neuroscience, 2019, Volume: 49, Issue:6

    Topics: Aged; Cholinergic Agents; Cholinergic Neurons; Corpus Striatum; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Neurons; Parkinson Disease

2019
Parkinson's Disease.
    The Medical clinics of North America, 2019, Volume: 103, Issue:2

    Topics: Antiparkinson Agents; Deep Brain Stimulation; Diagnosis, Differential; Humans; Hypokinesia; Levodopa; Parkinson Disease; Tremor

2019
The terminology of akinesia, bradykinesia and hypokinesia: Past, present and future.
    Parkinsonism & related disorders, 2017, Volume: 37

    Topics: Antiparkinson Agents; Forecasting; History, 19th Century; History, 20th Century; History, 21st Century; Humans; Hypokinesia; Levodopa; Parkinson Disease; Terminology as Topic

2017
    Presse medicale (Paris, France : 1983), 2017, Volume: 46, Issue:2 Pt 1

    Topics: Antiparkinson Agents; Articulation Disorders; Corpus Striatum; Deglutition Disorders; Disease Progression; Dopamine Agonists; Dopaminergic Neurons; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Movement; Muscle Hypertonia; Parkinson Disease; Parkinsonian Disorders; Postural Balance; Sensation Disorders; Substantia Nigra; Tremor

2017
Motor complications in Parkinson's disease.
    The International journal of neuroscience, 2011, Volume: 121 Suppl 2

    Topics: Drug Administration Schedule; Dyskinesia, Drug-Induced; Humans; Hypokinesia; Levodopa; Parkinson Disease

2011
Motor complications of Parkinson's disease.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2003, Volume: 24 Suppl 1

    Topics: Drug Resistance; Dyskinesia, Drug-Induced; Dyskinesias; Humans; Hypokinesia; Levodopa; Parkinson Disease; Treatment Failure

2003
Pathophysiology of motor fluctuations in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20 Suppl 11

    Topics: Adaptation, Physiological; Antiparkinson Agents; Basal Ganglia; Corpus Striatum; Cyclic AMP; Dyskinesia, Drug-Induced; Globus Pallidus; Humans; Hypokinesia; Levodopa; Muscle Rigidity; Neural Pathways; Parkinson Disease; Receptors, Neurotransmitter; Thalamus; Tremor

2005
Parkinson's disease. Diagnosis and the initiation of therapy.
    Minerva medica, 2005, Volume: 96, Issue:3

    Topics: Antioxidants; Diagnosis, Differential; Dopamine Agonists; Humans; Hypokinesia; Indans; Levodopa; Muscle Rigidity; Nerve Degeneration; Neuroprotective Agents; Parkinson Disease; Parkinsonian Disorders; Selegiline; Tremor

2005
[Freezing phenomenon in Parkinson disease].
    Fortschritte der Neurologie-Psychiatrie, 1997, Volume: 65, Issue:10

    Topics: Antiparkinson Agents; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Hypokinesia; Levodopa; Locus Coeruleus; Neurotransmitter Agents; Parkinson Disease; Physical Therapy Modalities; Substantia Nigra

1997
Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature.
    Movement disorders : official journal of the Movement Disorder Society, 2001, Volume: 16, Issue:3

    Topics: Adult; Age of Onset; Aged; Antiparkinson Agents; Australia; Canada; Drug Tolerance; Dyskinesia, Drug-Induced; Europe; Humans; Hypokinesia; Levodopa; Middle Aged; Parkinson Disease; Prevalence; Risk; Time Factors; United States

2001

Trials

21 trial(s) available for levodopa and Bradykinesia

ArticleYear
Levodopa Response in Patients With Early Parkinson Disease: Further Observations of the LEAP Study.
    Neurology, 2023, Jan-24, Volume: 100, Issue:4

    Topics: Aged; Antiparkinson Agents; Carbidopa; Double-Blind Method; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Tremor

2023
Dopamine-responsive and dopamine-resistant resting tremor in Parkinson disease.
    Neurology, 2020, 09-15, Volume: 95, Issue:11

    Topics: Accelerometry; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Dopamine Agents; Double-Blind Method; Drug Resistance; Female; Follow-Up Studies; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Netherlands; Parkinson Disease; Treatment Outcome; Tremor

2020
Auditory cueing of gait initiation in Parkinson's disease patients with freezing of gait.
    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2014, Volume: 125, Issue:8

    Topics: Analysis of Variance; Cues; Dopamine Agents; Female; Gait; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Posture

2014
Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2009, Feb-15, Volume: 24, Issue:3

    Topics: Aged; Antiparkinson Agents; Cognition Disorders; Combined Modality Therapy; Deep Brain Stimulation; Drug Resistance; Female; Follow-Up Studies; Functional Laterality; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Postoperative Care; Posture; Preoperative Care; Severity of Illness Index; Subthalamic Nucleus; Surveys and Questionnaires; Time Factors; Tremor

2009
Pathological synchronisation in the subthalamic nucleus of patients with Parkinson's disease relates to both bradykinesia and rigidity.
    Experimental neurology, 2009, Volume: 215, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Deep Brain Stimulation; Electroencephalography; Evoked Potentials; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Spectrum Analysis; Statistics as Topic; Subthalamic Nucleus

2009
Brain penetration effects of microelectrodes and DBS leads in STN or GPi.
    Journal of neurology, neurosurgery, and psychiatry, 2009, Volume: 80, Issue:7

    Topics: Aged; Antiparkinson Agents; Combined Modality Therapy; Deep Brain Stimulation; Electrodes, Implanted; Female; Follow-Up Studies; Globus Pallidus; Humans; Hypokinesia; Levodopa; Male; Microelectrodes; Middle Aged; Movement; Muscle Rigidity; Neurosurgical Procedures; Parkinson Disease; Subthalamic Nucleus; Treatment Outcome; Tremor

2009
Affect in Parkinson's disease: validation of the two-factor approach.
    Journal of the neurological sciences, 2010, Feb-15, Volume: 289, Issue:1-2

    Topics: Aged; Antidepressive Agents; Antiparkinson Agents; Depression; Dopamine; Female; Humans; Hyperkinesis; Hypokinesia; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Psychiatric Status Rating Scales; Reproducibility of Results; Serotonin; Time Factors

2010
Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease.
    European journal of neurology, 2011, Volume: 18, Issue:12

    Topics: Aged; Antiparkinson Agents; Catechols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Dysarthria; Facial Expression; Female; Humans; Hypokinesia; Indans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Motor Activity; Muscle Rigidity; Nitriles; Parkinson Disease; Severity of Illness Index; Tremor

2011
Unilateral caudal zona incerta deep brain stimulation for Parkinsonian tremor.
    Parkinsonism & related disorders, 2012, Volume: 18, Issue:10

    Topics: Aged; Antiparkinson Agents; Deep Brain Stimulation; Drug Resistance; Female; Follow-Up Studies; Functional Laterality; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Subthalamic Nucleus; Subthalamus; Treatment Outcome; Tremor

2012
Subthalamotomy for advanced Parkinson disease.
    Journal of neurosurgery, 2002, Volume: 97, Issue:3

    Topics: Aged; Antiparkinson Agents; Dyskinesias; Female; Functional Laterality; Humans; Hypokinesia; Levodopa; Magnetic Resonance Imaging; Male; Microelectrodes; Middle Aged; Parkinson Disease; Postoperative Complications; Radiosurgery; Subthalamic Nucleus; Treatment Outcome; Tremor

2002
Randomized trial of pallidotomy versus medical therapy for Parkinson's disease.
    Annals of neurology, 2003, Volume: 53, Issue:5

    Topics: Antiparkinson Agents; Atrophy; Brain; Carbidopa; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Combinations; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Globus Pallidus; Humans; Hypokinesia; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Rigidity; Neurosurgical Procedures; Parkinson Disease; Severity of Illness Index; Treatment Outcome; Tremor

2003
Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
    Archives of neurology, 2005, Volume: 62, Issue:4

    Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Deep Brain Stimulation; Female; Globus Pallidus; Humans; Hypokinesia; Intraoperative Complications; Levodopa; Male; Middle Aged; Parkinson Disease; Patient Selection; Pilot Projects; Postoperative Complications; Subthalamic Nucleus; Treatment Outcome; Tremor

2005
Neither simple nor sequential arm movements are bradykinetic in parkinsonian patients with peak-dose dyskinesias.
    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2005, Volume: 116, Issue:9

    Topics: Aged; Antiparkinson Agents; Arm; Biomechanical Phenomena; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Psychomotor Performance

2005
Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation.
    Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:9

    Topics: Adult; Aged; Antiparkinson Agents; Awareness; Combined Modality Therapy; Deep Brain Stimulation; Dominance, Cerebral; Dopamine Agonists; Double-Blind Method; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Placebo Effect; Set, Psychology; Subthalamic Nucleus

2006
Levodopa induced motor complications in Thai Parkinson's disease patients.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2006, Volume: 89, Issue:5

    Topics: Aged; Antiparkinson Agents; Disease Progression; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Hypokinesia; Levodopa; Male; Parkinson Disease; Thailand

2006
The efficacy of quantitative gait analysis by the GAITRite system in evaluation of parkinsonian bradykinesia.
    Parkinsonism & related disorders, 2006, Volume: 12, Issue:7

    Topics: Adult; Antiparkinson Agents; Diagnosis, Computer-Assisted; Disability Evaluation; Gait; Humans; Hypokinesia; Levodopa; Middle Aged; Parkinson Disease

2006
Cortical muscle coupling in Parkinson's disease (PD) bradykinesia.
    Journal of neural transmission. Supplementum, 2006, Issue:70

    Topics: Antiparkinson Agents; Data Collection; Electroencephalography; Electromyography; Humans; Hypokinesia; Levodopa; Motor Cortex; Muscle, Skeletal; Parkinson Disease; Psychomotor Performance

2006
Safety and efficacy of newly formulated selegiline orally disintegrating tablets as an adjunct to levodopa in the management of 'off' episodes in patients with Parkinson's disease.
    Current medical research and opinion, 2007, Volume: 23, Issue:4

    Topics: Administration, Oral; Aged; Antiparkinson Agents; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Polypharmacy; Selegiline; Tablets; Time Factors; Treatment Outcome

2007
Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2008, Jan-30, Volume: 23, Issue:2

    Topics: Aged; Antiparkinson Agents; Deep Brain Stimulation; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Subthalamic Nucleus; Task Performance and Analysis; Treatment Outcome

2008
Ventroposterolateral pallidotomy.
    Stereotactic and functional neurosurgery, 1994, Volume: 62, Issue:1-4

    Topics: Adult; Aged; Drug Resistance; Globus Pallidus; Humans; Hypokinesia; Levodopa; Middle Aged; Parkinson Disease; Psychomotor Performance; Thalamus

1994
Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients.
    Journal of neurosurgery, 2001, Volume: 95, Issue:2

    Topics: Adult; Aged; Antiparkinson Agents; Electric Stimulation Therapy; Female; Follow-Up Studies; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Severity of Illness Index; Subthalamic Nucleus; Time Factors; Treatment Outcome; Tremor

2001

Other Studies

83 other study(ies) available for levodopa and Bradykinesia

ArticleYear
Comparative Analysis of Acute Levodopa Challenge Test and the Outcomes of Deep Brain Stimulation in Parkinson's Disease.
    Journal of neurological surgery. Part A, Central European neurosurgery, 2022, Volume: 83, Issue:6

    Topics: Deep Brain Stimulation; Humans; Hypokinesia; Levodopa; Muscle Rigidity; Parkinson Disease; Subthalamic Nucleus; Treatment Outcome

2022
Amplitude setting and dopamine response of finger tapping and gait are related in Parkinson's disease.
    Scientific reports, 2022, 03-09, Volume: 12, Issue:1

    Topics: Dopamine; Gait; Humans; Hypokinesia; Levodopa; Parkinson Disease

2022
The Impact of Wearable Electronics in Assessing the Effectiveness of Levodopa Treatment in Parkinson's Disease.
    IEEE journal of biomedical and health informatics, 2022, Volume: 26, Issue:7

    Topics: Humans; Hypokinesia; Levodopa; Parkinson Disease; Tremor; Wearable Electronic Devices

2022
Clinical correlates of movement disorders in adult Niemann-Pick type C patients measured via a Personal KinetiGraph.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022, Volume: 43, Issue:11

    Topics: Adult; Dyskinesias; Humans; Hypokinesia; Levodopa; Niemann-Pick Disease, Type C; Parkinson Disease

2022
The effect of age and disease duration on the efficacy of subthalamic nuclei deep brain stimulation in Parkinson's disease patients.
    CNS neuroscience & therapeutics, 2022, Volume: 28, Issue:12

    Topics: Deep Brain Stimulation; Humans; Hypokinesia; Levodopa; Parkinson Disease; Subthalamic Nucleus; Treatment Outcome

2022
[Clinical and genetic characteristics of children with dopa-responsive dystonia caused by tyrosine hydroxylase gene variations].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2023, Apr-02, Volume: 61, Issue:4

    Topics: Benserazide; Dystonia; Female; Humans; Hypokinesia; Infant; Levodopa; Male; Muscle Hypotonia; Retrospective Studies; Tyrosine 3-Monooxygenase

2023
Hypomimia in Parkinson's disease: an axial sign responsive to levodopa.
    European journal of neurology, 2020, Volume: 27, Issue:12

    Topics: Antiparkinson Agents; Facial Expression; Humans; Hypokinesia; Levodopa; Mental Status and Dementia Tests; Parkinson Disease; Quality of Life

2020
Predictors of Pharyngeal Dysphagia in Patients with Parkinson's Disease.
    Journal of Parkinson's disease, 2020, Volume: 10, Issue:4

    Topics: Age Factors; Aged; Antiparkinson Agents; Deglutition Disorders; Female; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Postural Balance; Risk; Severity of Illness Index; Tremor

2020
Assessment of Wearing Off in Parkinson's disease using objective measurement.
    Journal of neurology, 2021, Volume: 268, Issue:3

    Topics: Antiparkinson Agents; Humans; Hypokinesia; Levodopa; Parkinson Disease; Quality of Life

2021
Comparison of effectiveness of trihexyphenidyl and levodopa on motor symptoms in Parkinson's disease.
    Journal of neural transmission (Vienna, Austria : 1996), 2020, Volume: 127, Issue:12

    Topics: Antiparkinson Agents; Humans; Hypokinesia; Infant, Newborn; Levodopa; Parkinson Disease; Treatment Outcome; Tremor; Trihexyphenidyl

2020
Parkinson's disease medication state and severity assessment based on coordination during walking.
    PloS one, 2021, Volume: 16, Issue:2

    Topics: Aged; Dopamine Agents; Female; Gait; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Postural Balance; Psychomotor Performance; Severity of Illness Index; Walking; Wearable Electronic Devices

2021
Treatment of unexplained coma and hypokinetic-rigid syndrome in a patient with COVID-19.
    BMJ case reports, 2021, Mar-02, Volume: 14, Issue:3

    Topics: Blood Coagulation; Brain Diseases; Carbidopa; Central Nervous System Stimulants; Cognitive Dysfunction; COVID-19; Critical Care; Drug Combinations; Humans; Hypokinesia; Ischemic Stroke; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Modafinil; Rehabilitation; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Ventilator Weaning

2021
A method for measuring time spent in bradykinesia and dyskinesia in people with Parkinson's disease using an ambulatory monitor.
    Journal of neuroengineering and rehabilitation, 2021, 07-16, Volume: 18, Issue:1

    Topics: Algorithms; Antiparkinson Agents; Dyskinesias; Humans; Hypokinesia; Levodopa; Parkinson Disease

2021
Comparison of the Parkinson's KinetiGraph to off/on levodopa response testing: Single center experience.
    Clinical neurology and neurosurgery, 2021, Volume: 209

    Topics: Aged; Antiparkinson Agents; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Symptom Assessment; Treatment Outcome

2021
Recuperation of slow walking in de novo Parkinson's disease is more closely associated with increased cadence, rather than with expanded stride length.
    Gait & posture, 2017, Volume: 58

    Topics: Aged; Female; Gait; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Walking; Walking Speed

2017
Bereitschaftspotential preceding eyelid blinks in Parkinson's disease.
    Arquivos de neuro-psiquiatria, 2017, Volume: 75, Issue:8

    Topics: Adult; Aged; Analysis of Variance; Antiparkinson Agents; Blinking; Case-Control Studies; Contingent Negative Variation; Electrodes, Implanted; Electroencephalography; Eyelids; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Motor Cortex; Movement; Parkinson Disease; Time Factors

2017
The placebo effect on bradykinesia in Parkinson's disease with and without prior drug conditioning.
    Movement disorders : official journal of the Movement Disorder Society, 2017, Volume: 32, Issue:10

    Topics: Aged; Apomorphine; Dopamine Agents; Female; Follow-Up Studies; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Placebo Effect

2017
Aberrant learning in Parkinson's disease: A neurocomputational study on bradykinesia.
    The European journal of neuroscience, 2018, Volume: 47, Issue:12

    Topics: Basal Ganglia; Dopamine; Dopamine Agents; Humans; Hypokinesia; Levodopa; Models, Theoretical; Neuronal Plasticity; Parkinson Disease; Psychomotor Performance

2018
Neurophysiological correlates of bradykinesia in Parkinson's disease.
    Brain : a journal of neurology, 2018, 08-01, Volume: 141, Issue:8

    Topics: Aged; Biomechanical Phenomena; Evoked Potentials, Motor; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Motor Cortex; Movement; Neuronal Plasticity; Neurophysiology; Parkinson Disease; Transcranial Magnetic Stimulation

2018
Impaired finger dexterity and nigrostriatal dopamine loss in Parkinson's disease.
    Journal of neural transmission (Vienna, Austria : 1996), 2018, Volume: 125, Issue:9

    Topics: Aged; Antiparkinson Agents; Apraxias; Arm; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Female; Fingers; Functional Laterality; Humans; Hypokinesia; Imaging, Three-Dimensional; Levodopa; Male; Middle Aged; Motor Skills; Muscle Rigidity; Parkinson Disease; Positron-Emission Tomography; Severity of Illness Index; Substantia Nigra

2018
Fact-finding survey on diagnostic procedures and therapeutic interventions for parkinsonism accompanying dementia with Lewy bodies.
    Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2019, Volume: 19, Issue:4

    Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Lewy Body Disease; Middle Aged; Muscle Rigidity; Neurologists; Parkinsonian Disorders; Physicians; Postural Balance; Psychiatry; Psychotropic Drugs; Tremor

2019
The Use of Data from the Parkinson's KinetiGraph to Identify Potential Candidates for Device Assisted Therapies.
    Sensors (Basel, Switzerland), 2019, May-15, Volume: 19, Issue:10

    Topics: Aged; Algorithms; Deep Brain Stimulation; Dyskinesias; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Sensitivity and Specificity; Tremor

2019
Distinct subthalamic coupling in the ON state describes motor performance in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2020, Volume: 35, Issue:1

    Topics: Adult; Aged; Beta Rhythm; Deep Brain Stimulation; Dopamine Agents; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Subthalamic Nucleus

2020
Comparing kinematic changes between a finger-tapping task and unconstrained finger flexion-extension task in patients with Parkinson's disease.
    Experimental brain research, 2013, Volume: 227, Issue:3

    Topics: Antiparkinson Agents; Biomechanical Phenomena; Female; Fingers; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Psychomotor Performance

2013
Choreo-athetosis in LRRK2 R1441C mutation: expanding the clinical phenotype.
    Clinical neurology and neurosurgery, 2013, Volume: 115, Issue:10

    Topics: Antiparkinson Agents; Athetosis; Benzothiazoles; Chorea; Female; Gait Disorders, Neurologic; Humans; Hypokinesia; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Levodopa; Magnetic Resonance Imaging; Middle Aged; Mutation; Neurologic Examination; Phenotype; Positron-Emission Tomography; Pramipexole; Protein Serine-Threonine Kinases; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Tremor

2013
Automated assessment of bradykinesia and dyskinesia in Parkinson's disease.
    Journal of Parkinson's disease, 2012, Volume: 2, Issue:1

    Topics: Adult; Algorithms; Antiparkinson Agents; Case-Control Studies; Dyskinesias; Electronic Data Processing; Female; Humans; Hypokinesia; Levodopa; Male; Parkinson Disease; Spectrum Analysis; Time Factors

2012
Acute morphine treatments alleviate tremor in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys.
    PloS one, 2014, Volume: 9, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Hypokinesia; Levodopa; Macaca mulatta; Male; Morphine; Motor Activity; Parkinson Disease; Postural Balance; Tremor

2014
A conditioned response as a measure of impulsive-compulsive behaviours in Parkinson's disease.
    PloS one, 2014, Volume: 9, Issue:2

    Topics: Aged; Anxiety; Apathy; Compulsive Behavior; Conditioning, Psychological; Depression; Disruptive, Impulse Control, and Conduct Disorders; Dyskinesias; Humans; Hypokinesia; Impulsive Behavior; Levodopa; Middle Aged; Parkinson Disease; Weights and Measures

2014
[Tyrosine hydroxylase deficiency: a case of autosomal recessive dopa-responsive dystonia].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2014, Volume: 52, Issue:8

    Topics: Brain; Catecholamines; Child, Preschool; DNA; DNA Mutational Analysis; Dopamine Agents; Dystonic Disorders; Homozygote; Humans; Hypokinesia; Levodopa; Male; Muscle Rigidity; Mutation, Missense; Polymerase Chain Reaction; Tyrosine 3-Monooxygenase

2014
Delayed chorea after recovery from severe akinetic-rigid parkinsonism caused by extrapontine myelinolysis.
    Journal of the neurological sciences, 2015, Nov-15, Volume: 358, Issue:1-2

    Topics: Carbidopa; Chorea; Disease Progression; Dopamine Agonists; Drug Combinations; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Myelinolysis, Central Pontine; Parkinsonian Disorders

2015
An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque models.
    Neuropharmacology, 2016, Volume: 110, Issue:Pt A

    Topics: Adenosine A2 Receptor Antagonists; Animals; Cognition Disorders; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Hypokinesia; Levodopa; Macaca fascicularis; Motor Skills Disorders; MPTP Poisoning; Purines; Treatment Outcome

2016
Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016, 08-31, Volume: 36, Issue:35

    Topics: Adrenergic Agents; Amphetamine; Analysis of Variance; Animals; Choline O-Acetyltransferase; Cholinergic Neurons; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Functional Laterality; Genotype; Hypokinesia; Levodopa; Luminescent Proteins; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Optogenetics; Oxidopamine; Parkinson Disease; Receptor, Muscarinic M1; Receptor, Muscarinic M4; Transduction, Genetic

2016
The clinical spectrum and natural history of pure akinesia with gait freezing.
    Journal of neurology, 2016, Volume: 263, Issue:12

    Topics: Aged; Aged, 80 and over; Dopamine Agents; Female; Follow-Up Studies; Freezing Reaction, Cataleptic; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Neuroimaging; Postural Balance; Psychomotor Performance; Retrospective Studies

2016
Learning brain connectivity with the false-discovery-rate-controlled PC-algorithm.
    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2008, Volume: 2008

    Topics: Algorithms; Bayes Theorem; Brain; False Positive Reactions; Humans; Hypokinesia; Levodopa; Magnetic Resonance Imaging; Models, Neurological; Models, Statistical; Nerve Net; Parkinson Disease; Reproducibility of Results

2008
The CB(1) antagonist rimonabant is adjunctively therapeutic as well as monotherapeutic in an animal model of Parkinson's disease.
    Behavioural brain research, 2009, Nov-05, Volume: 203, Issue:2

    Topics: Animals; Corpus Striatum; Disease Models, Animal; Hypokinesia; Levodopa; Male; Motor Activity; Oxidopamine; Parkinson Disease; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Receptor, Cannabinoid, CB1; Rimonabant

2009
Stepping test in mice: a reliable approach in determining forelimb akinesia in MPTP-induced Parkinsonism.
    Experimental neurology, 2009, Volume: 219, Issue:1

    Topics: Animals; Antiparkinson Agents; Cell Count; Disease Models, Animal; Forelimb; Hypokinesia; Lameness, Animal; Levodopa; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neurologic Examination; Parkinsonian Disorders; Predictive Value of Tests; Sensitivity and Specificity; Substantia Nigra

2009
The selective D(3) receptor antagonist, S33084, improves parkinsonian-like motor dysfunction but does not affect L-DOPA-induced dyskinesia in 6-hydroxydopamine hemi-lesioned rats.
    Neuropharmacology, 2010, Volume: 58, Issue:2

    Topics: Animals; Antiparkinson Agents; Benzopyrans; Disability Evaluation; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Hypokinesia; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D3; Time Factors; Treatment Outcome

2010
Comparative analysis of gait and speech in Parkinson's disease: hypokinetic or dysrhythmic disorders?
    Journal of neurology, neurosurgery, and psychiatry, 2010, Volume: 81, Issue:2

    Topics: Aged; Antiparkinson Agents; Female; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Speech; Speech Disorders; Walking

2010
Impaired awareness of movement disorders in Parkinson's disease.
    Brain and cognition, 2010, Volume: 72, Issue:3

    Topics: Adult; Aged; Agnosia; Analysis of Variance; Antiparkinson Agents; Awareness; Female; Humans; Hypokinesia; Levodopa; Middle Aged; Movement Disorders; Neuropsychological Tests; Parkinson Disease; Self Concept; Statistics, Nonparametric

2010
Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis.
    Brain : a journal of neurology, 2010, Volume: 133, Issue:Pt 6

    Topics: Age of Onset; Amino Acid Metabolism, Inborn Errors; Brain; Brain Diseases; Catecholamines; Child, Preschool; Disease Progression; Dopamine Agents; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Hypokinesia; Infant; Levodopa; Muscle Rigidity; Mutation, Missense; Phenotype; Promoter Regions, Genetic; Severity of Illness Index; Tyrosine 3-Monooxygenase

2010
Differential response of speed, amplitude, and rhythm to dopaminergic medications in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2011, Volume: 26, Issue:14

    Topics: Aged; Aged, 80 and over; Dopamine Agents; Drug Monitoring; Humans; Hypokinesia; Levodopa; Middle Aged; Movement; Neurologic Examination; Neurology; Observer Variation; Parkinson Disease; Videotape Recording

2011
Development of Parkinson's disease in patients with Narcolepsy.
    Journal of neural transmission (Vienna, Austria : 1996), 2012, Volume: 119, Issue:6

    Topics: Adult; Age of Onset; Antiparkinson Agents; Cataplexy; Central Nervous System Stimulants; Deep Brain Stimulation; Dextroamphetamine; Female; Humans; Hypokinesia; Indans; International Classification of Diseases; Levodopa; Male; Middle Aged; Narcolepsy; Neuroprotective Agents; Parkinson Disease; Sleep; Young Adult

2012
Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease.
    Brain : a journal of neurology, 2012, Volume: 135, Issue:Pt 4

    Topics: Aged; Analysis of Variance; Biomechanical Phenomena; Case-Control Studies; Cognition; Disease Progression; Dopamine Agents; Female; Fingers; Handwriting; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Psychomotor Performance; Supranuclear Palsy, Progressive

2012
β band stability over time correlates with Parkinsonian rigidity and bradykinesia.
    Experimental neurology, 2012, Volume: 236, Issue:2

    Topics: Aged; Basal Ganglia; Beta Rhythm; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Time Factors

2012
A common optimization principle for motor execution in healthy subjects and parkinsonian patients.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013, Jan-09, Volume: 33, Issue:2

    Topics: Acceleration; Aged; Algorithms; Antiparkinson Agents; Biomechanical Phenomena; Data Interpretation, Statistical; Deep Brain Stimulation; Executive Function; Female; Humans; Hypokinesia; Individuality; Isotonic Contraction; Levodopa; Male; Middle Aged; Models, Neurological; Motor Skills; Parkinsonian Disorders; Reaction Time

2013
Antimicrobial surveillance in idiopathic parkinsonism: indication-specific improvement in hypokinesia following Helicobacter pylori eradication and non-specific effect of antimicrobials for other indications in worsening rigidity.
    Helicobacter, 2013, Volume: 18, Issue:3

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiparkinson Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hypokinesia; Intestine, Small; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinsonian Disorders; Treatment Outcome

2013
Impaired regulation of stride variability in Parkinson's disease subjects with freezing of gait.
    Experimental brain research, 2003, Volume: 149, Issue:2

    Topics: Aged; Female; Gait; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Regression Analysis; Statistics, Nonparametric; Walking

2003
Treatment of advanced Parkinson's disease by subthalamotomy: one-year results.
    Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:5

    Topics: Adult; Aged; Antiparkinson Agents; Dyskinesias; Electrocoagulation; Female; Follow-Up Studies; Humans; Hypokinesia; Levodopa; Magnetic Resonance Imaging; Male; Microelectrodes; Middle Aged; Parkinson Disease; Postoperative Complications; Posture; Severity of Illness Index; Subthalamic Nucleus; Surveys and Questionnaires; Time

2003
Gaucher's disease with Parkinson's disease: clinical and pathological aspects.
    Neurology, 2003, Jul-08, Volume: 61, Issue:1

    Topics: Adult; Age of Onset; Aged; Anemia; Antiparkinson Agents; Disease Progression; DNA Mutational Analysis; Drug Resistance; Female; Gaucher Disease; Glucosylceramidase; Hepatomegaly; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Recombinant Proteins; Siblings; Splenomegaly; Thrombocytopenia; Tremor

2003
Heart rate variability and Parkinson's disease severity.
    Journal of neural transmission (Vienna, Austria : 1996), 2003, Volume: 110, Issue:9

    Topics: Autonomic Nervous System Diseases; Cardiovascular System; Chronobiology Disorders; Disease Progression; Female; Heart Rate; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Surveys and Questionnaires; Sympathetic Nervous System; Up-Regulation; Vagus Nerve

2003
Relationship between freezing of gait (FOG) and other features of Parkinson's: FOG is not correlated with bradykinesia.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2003, Volume: 10, Issue:5

    Topics: Antiparkinson Agents; Gait Ataxia; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Motor Activity; Movement Disorders; Parkinson Disease; Postural Balance; Speech Disorders; Tremor

2003
A paradoxical acute effect of levodopa in de novo parkinsonian patients: worsening of some bradykinetic components.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2003, Volume: 24, Issue:3

    Topics: Acoustic Stimulation; Aged; Antiparkinson Agents; Choice Behavior; Drug Administration Schedule; Electromyography; Female; Humans; Hypokinesia; Levodopa; Male; Parkinsonian Disorders; Reaction Time

2003
Subthalamic stimulation influences postmovement cortical somatosensory processing in Parkinson's disease.
    The European journal of neuroscience, 2003, Volume: 18, Issue:7

    Topics: Aged; Antiparkinson Agents; Beta Rhythm; Brain Mapping; Electric Stimulation; Electroencephalography; Electromyography; Electronic Data Processing; Female; Functional Laterality; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Somatosensory Cortex; Subthalamic Nucleus

2003
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropinirole.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 309, Issue:3

    Topics: Acetylcholine; Animals; Callithrix; Cells, Cultured; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Drug Interactions; Dyskinesias; Electrophysiology; Extracellular Space; Humans; Hypokinesia; Indoles; Levodopa; Male; Motor Activity; MPTP Poisoning; Neuroprotective Agents; Oxazines; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Reserpine; Rotation

2004
Pathophysiology of parkinsonism due to hydrocephalus.
    Journal of neurology, neurosurgery, and psychiatry, 2004, Volume: 75, Issue:11

    Topics: Adult; Antiparkinson Agents; Brain Mapping; Carbidopa; Caudate Nucleus; Cerebral Ventricles; Drug Combinations; Equipment Failure; Humans; Hydrocephalus; Hypokinesia; Levodopa; Magnetic Resonance Imaging; Male; Neurologic Examination; Parkinsonian Disorders; Positron-Emission Tomography; Postoperative Complications; Putamen; Ventriculoperitoneal Shunt

2004
Effects of disease progression and L-dopa therapy on the control of reaching-grasping in Parkinson's disease.
    Neuropsychologia, 2005, Volume: 43, Issue:3

    Topics: Aged; Antiparkinson Agents; Basal Ganglia; Biomechanical Phenomena; Case-Control Studies; Disease Progression; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Motor Skills Disorders; Parkinson Disease; Severity of Illness Index; Task Performance and Analysis

2005
Parkinsonian action tremor: interference with object manipulation and lacking levodopa response.
    Experimental neurology, 2005, Volume: 194, Issue:1

    Topics: Adult; Aged; Dopamine Agents; Female; Hand; Hand Strength; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Motor Skills; Movement; Parkinson Disease; Tremor; Weight-Bearing

2005
Effects of deep brain stimulation and medication on strength, bradykinesia, and electromyographic patterns of the ankle joint in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:1

    Topics: Ankle Joint; Antiparkinson Agents; Biomechanical Phenomena; Carbidopa; Combined Modality Therapy; Deep Brain Stimulation; Electrodes, Implanted; Electromyography; Humans; Hypokinesia; Isometric Contraction; Levodopa; Muscle Weakness; Muscle, Skeletal; Parkinson Disease; Reference Values; Signal Processing, Computer-Assisted; Statistics as Topic; Torque; Treatment Outcome; Tremor

2006
Ambulatory motor assessment in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:1

    Topics: Activities of Daily Living; Adult; Aged; Algorithms; Antiparkinson Agents; Female; Humans; Hypokinesia; Levodopa; Male; Mathematical Computing; Middle Aged; Monitoring, Ambulatory; Neurologic Examination; Parkinson Disease; Reproducibility of Results; Signal Processing, Computer-Assisted; Tremor; Videotape Recording

2006
Gender and the Parkinson's disease phenotype.
    Journal of neurology, 2005, Volume: 252, Issue:10

    Topics: Activities of Daily Living; Age of Onset; Analysis of Variance; Antiparkinson Agents; Chi-Square Distribution; Cohort Studies; Databases, Factual; Depression; Female; Functional Laterality; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Muscle Rigidity; Parkinson Disease; Phenotype; Retrospective Studies; Sex Factors; Time Factors; Tremor

2005
Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation.
    Neurology, 2005, Dec-13, Volume: 65, Issue:11

    Topics: Adult; Age of Onset; Brain; Dopamine; Ethnicity; Female; Genetic Carrier Screening; Genetic Predisposition to Disease; Heterozygote; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Mutation; Parkinson Disease; Tremor; Ubiquitin-Protein Ligases

2005
Progression of Parkinson's disease following thalamic deep brain stimulation for tremor.
    Stereotactic and functional neurosurgery, 2005, Volume: 83, Issue:5-6

    Topics: Aged; Deep Brain Stimulation; Disease Progression; Follow-Up Studies; Gait; Humans; Hypokinesia; Levodopa; Middle Aged; Motor Skills; Muscle Rigidity; Parkinson Disease; Severity of Illness Index; Thalamus; Tremor; Verbal Behavior

2005
Bradykinesia in patients with Parkinson's disease having levodopa-induced dyskinesias.
    Brain research bulletin, 2006, May-15, Volume: 69, Issue:5

    Topics: Aged; Antiparkinson Agents; Dyskinesia, Drug-Induced; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Psychomotor Performance

2006
Excellent response to apomorphine in Parkinsonism with optic atrophy unresponsive to oral antiparkinsonian medication.
    Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:9

    Topics: Administration, Oral; Amantadine; Antiparkinson Agents; Apomorphine; Combined Modality Therapy; Deep Brain Stimulation; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Humans; Hypokinesia; Infusions, Intravenous; Injections, Subcutaneous; Levodopa; Middle Aged; Neurologic Examination; Optic Atrophy; Parkinson Disease

2006
The sequence effect and gait festination in Parkinson disease: contributors to freezing of gait?
    Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:9

    Topics: Aged; Antiparkinson Agents; Attention; Basal Ganglia; Cues; Drug Therapy, Combination; Female; Gait Apraxia; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Mobility Limitation; Neurologic Examination; Parkinson Disease; Risk Factors; Sensory Deprivation; Visual Perception; Walking

2006
Dopa-responsive infantile hypokinetic rigid syndrome due to dominant guanosine triphosphate cyclohydrolase 1 deficiency.
    Journal of the neurological sciences, 2007, May-15, Volume: 256, Issue:1-2

    Topics: Antiparkinson Agents; Family Health; Female; GTP Cyclohydrolase; Humans; Hypokinesia; Infant; Levodopa; Male; Muscle Rigidity; Retrospective Studies

2007
Bilateral subthalamotomy for advanced Parkinson disease.
    Surgical neurology, 2007, Volume: 68 Suppl 1

    Topics: Aged; Catheter Ablation; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Functional Laterality; Humans; Hypokinesia; Levodopa; Male; Microelectrodes; Middle Aged; Muscle Rigidity; Neural Pathways; Parkinson Disease; Radiosurgery; Subthalamic Nucleus; Time; Treatment Outcome; Tremor

2007
Factors predicting response to dopaminergic treatment for resting tremor of Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2008, Volume: 23, Issue:1

    Topics: Aged; Demography; Dopamine Agonists; Extremities; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Posture; Prospective Studies; Rest; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Tremor

2008
Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
    Acta neurochirurgica, 2008, Volume: 150, Issue:1

    Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Deep Brain Stimulation; Dyskinesias; Electrodes, Implanted; Female; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Posture; Psychoses, Substance-Induced; Retrospective Studies; Subthalamic Nucleus; Tremor

2008
The evolution of disability in Parkinson disease.
    Movement disorders : official journal of the Movement Disorder Society, 2008, Apr-30, Volume: 23, Issue:6

    Topics: Activities of Daily Living; Aged; Diagnosis, Differential; Disabled Persons; Disease Progression; Female; Gait Disorders, Neurologic; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Self Care; Severity of Illness Index; Tremor

2008
Hypokinesia in Parkinson's disease: influence of age, disease severity, and disease duration.
    Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:4

    Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Circadian Rhythm; Drug Therapy, Combination; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Motor Activity; Muscle Rigidity; Neurologic Examination; Parkinson Disease

1995
Striatal dopamine depletion, tremors, and hypokinesia following the intracranial injection of S-adenosylmethionine: a possible role of hypermethylation in parkinsonism.
    Molecular and chemical neuropathology, 1995, Volume: 26, Issue:3

    Topics: Animals; Antiparkinson Agents; Caudate Nucleus; Dopamine; Dose-Response Relationship, Drug; Hypokinesia; Injections, Intraventricular; Levodopa; Male; Methylation; Motor Activity; Neostriatum; Parkinson Disease; Rats; Rats, Sprague-Dawley; S-Adenosylhomocysteine; S-Adenosylmethionine; Tremor

1995
High-frequency stimulation of the globus pallidus internalis in Parkinson's disease: a study of seven cases.
    Journal of neurosurgery, 1997, Volume: 87, Issue:4

    Topics: Adult; Disease Progression; Dyskinesia, Drug-Induced; Electric Stimulation Therapy; Electrodes, Implanted; Follow-Up Studies; Gait; Globus Pallidus; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Speech Disorders; Stereotaxic Techniques; Thalamic Nuclei; Treatment Outcome; Tremor

1997
Bilateral posteroventral pallidotomy in advanced Parkinson's disease in three patients.
    Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:5

    Topics: Activities of Daily Living; Age of Onset; Antiparkinson Agents; Drug Resistance; Dyskinesia, Drug-Induced; Dystonia; Female; Follow-Up Studies; Globus Pallidus; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Pilot Projects; Prospective Studies; Severity of Illness Index; Treatment Outcome

1997
Abnormalities in the stride length-cadence relation in parkinsonian gait.
    Movement disorders : official journal of the Movement Disorder Society, 1998, Volume: 13, Issue:1

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Case-Control Studies; Female; Gait; Humans; Hypokinesia; Levodopa; Linear Models; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Time and Motion Studies

1998
Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP.
    Psychopharmacology, 1999, Volume: 147, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine; Animals; Antiparkinson Agents; Antipsychotic Agents; Caffeine; Catalepsy; Dopamine Agents; Hypokinesia; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; Phenethylamines; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purines; Reserpine; Theophylline

1999
The influence of L-dopa on methylation capacity in aromatic L-amino acid decarboxylase deficiency: biochemical findings in two patients.
    Journal of inherited metabolic disease, 2000, Volume: 23, Issue:4

    Topics: Amino Acid Metabolism, Inborn Errors; Aromatic-L-Amino-Acid Decarboxylases; Dopamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Hypokinesia; Levodopa; Methoxyhydroxyphenylglycol; Methylation; Muscle Hypotonia; Tetrahydrofolates; Tyrosine

2000
Reduction of dyskinesia and induction of akinesia induced by morphine in two parkinsonian patients with severe sciatica.
    Journal of neural transmission (Vienna, Austria : 1996), 1999, Volume: 106, Issue:7-8

    Topics: Aged; Analgesics, Opioid; Antiparkinson Agents; Dyskinesia, Drug-Induced; Humans; Hypokinesia; Intervertebral Disc Displacement; Levodopa; Lumbar Vertebrae; Male; Middle Aged; Morphine; Parkinson Disease; Sciatica

1999
A dynamical-systems model for Parkinson's disease.
    Biological cybernetics, 2000, Volume: 83, Issue:1

    Topics: Antiparkinson Agents; Gait; Humans; Hypokinesia; Levodopa; Models, Neurological; Movement; Parkinson Disease; Posture

2000
Mu- and delta-opioid receptor antagonists reduce levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease.
    Experimental neurology, 2001, Volume: 171, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Callithrix; Disease Models, Animal; Drug Therapy, Combination; Dyskinesias; Female; Hypokinesia; Levodopa; Male; Morphinans; Motor Activity; Naltrexone; Narcotic Antagonists; Parkinsonian Disorders; Posture; Receptors, Opioid, delta; Receptors, Opioid, mu

2001
Clinical correlates of action tremor in Parkinson disease.
    Archives of neurology, 2001, Volume: 58, Issue:10

    Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Antiparkinson Agents; Arm; Female; Humans; Hypokinesia; Levodopa; Male; Mental Status Schedule; Middle Aged; Motor Activity; Movement; Muscle Rigidity; Parkinson Disease; Physical Examination; Posture; Rest; Tremor; Video Recording

2001
Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4-tetrahydroisoquinolines on a mouse model of Parkinson's disease.
    Brain research bulletin, 2001, Sep-01, Volume: 56, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Carbidopa; Cell Count; Disease Models, Animal; Dopamine; Dopamine Antagonists; Drug Interactions; Homovanillic Acid; Hydroxyindoleacetic Acid; Hypokinesia; Immunohistochemistry; Isoquinolines; Levodopa; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Neurotoxins; Parkinsonian Disorders; Serotonin; Stereoisomerism; Substantia Nigra; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase

2001
Interaction of levodopa and cues on voluntary reaching in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:1

    Topics: Antiparkinson Agents; Cues; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index

2002